Raymond James Financial’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Raymond James Financial's GPCR Position: Q3 2026 in Review
Raymond James Financial sold out of Structure Therapeutics (GPCR) in Q3 2026, closing a stake of 59,357 shares — an estimated $3.19M sold.
Raymond James Financial first reported a position in GPCR in Q2 2025 and held it in 4 quarters. The position peaked at $3.19M in Q2 2026. 169 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Raymond James Financial reported no remaining Structure Therapeutics position as of Q3 2026 after selling out during the quarter.
- Raymond James Financial sold 59,357 Structure Therapeutics shares in Q3 2026, an estimated $3.19M.
- Raymond James Financial first reported a position in Structure Therapeutics in Q2 2025 and held it in 4 quarters.
- Raymond James Financial's Structure Therapeutics position peaked at $3.19M in Q2 2026.
- 169 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.